Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04737499 · ClinicalTrials.gov registry record · NA
Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe)
A NA study, sponsored by Claremont Graduate University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04737499: Completed NA study, sponsored by Claremont Graduate University.
NCT04737499 is a NA study that has completed, run by Claremont Graduate University. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04737499, a NA study, has completed, sponsored by Claremont Graduate University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The project aimed to evaluate the implementation process and efficacy of a culturally tailored Diabetes Self-Management and Education (DSME) program with mobile health (mHealth) technology integration, entitled Culturally Appropriate Strategies for Chinese Americans with Diabetes (CASCADe), among Chinese American adults with Type 2 diabetes.
Primary Outcome
HbA1c was assessed using the testing kit of A1C Now+ with a finger prick of blood by trained data collector.
Interventions
- BEHAVIORAL CASCADe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-07-05 |
| Est. Completion | 2018-03-20 |
| Phase | NA |
What the finished NCT04737499 record still lists
NCT04737499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which CASCADe is the first listed.
NCT04737499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04737499 about?
NCT04737499 is a clinical study titled "Culturally Appropriate Strategies for Chinese Americans With Diabetes (CASCADe)". The project aimed to evaluate the implementation process and efficacy of a culturally tailored Diabetes Self-Management and Education (DSME) program with mobile health (mHealth) technology integration, entitled Culturally Appropriate Strategies for Chinese Americans with Diabetes (CASCADe), among Ch...
What is the current status of trial NCT04737499?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-07-05. Estimated completion is 2018-03-20.
What interventions are being tested in trial NCT04737499?
The interventions under investigation include: CASCADe (BEHAVIORAL).
Who is sponsoring clinical trial NCT04737499?
This trial is sponsored by Claremont Graduate University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04737499's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy